Concepedia

John T. Nelson

JT

Statistics

Publications

12

Citations

517

H-Index

11

Active since

1950

Affiliations

Genomics Institute of the Novartis Research Foundation(Current)

Novartis (United States)

John T. Nelson is an author at Genomics Institute of the Novartis Research Foundation specializing in pharmacology, medicine, and drug discovery.

Publications per year

1950–2021

12

Publications

12

The Design, Synthesis, and Evaluation of Coumarin Ring Derivatives of the Novobiocin Scaffold that Exhibit Antiproliferative Activity

Alison C. Donnelly, Jared R. Mays, Joseph A. Burlison et al. · The Journal of Organic Chemistry · 2008 · 153 citations · Full text

, , +10

Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis

D. CHIANELLI, Paul V. Rucker, Jason Roland et al. · Journal of Medicinal Chemistry · 2020 · 99 citations · Full text

, , +16

Examining the myth of the “July Phenomenon” in surgical patients

Bryan A. Ehlert, John T. Nelson, Claudia E. Goettler et al. · Surgery · 2011 · 57 citations

, , +10

Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases

Xiaohui He, Sara Da Ros, John T. Nelson et al. · ACS Medicinal Chemistry Letters · 2017 · 53 citations · Full text

, , +17

Efficacy and Tolerability of Pyrazolo[1,5-<i>a</i>]pyrimidine RET Kinase Inhibitors for the Treatment of Lung Adenocarcinoma

Casey J. N. Mathison, D. CHIANELLI, Paul V. Rucker et al. · ACS Medicinal Chemistry Letters · 2020 · 26 citations · Full text

, , +14

1–5 of 12